A Convergence Problem: Getting the Drug on the Device
Executive Summary
Drug-eluting stents are highly successful medical devices but even their manufacturers don't have adequate solutions for a hidden problem in drug-device combinations; the best way to get the drug on the device. Sarnoff Corp.has a new technology for addressing this complex process. Called electro-static deposition, it brings increased flexibility, reproducibility, accuracy, and uniformity to a manufacturing process which using current methods is costly and inefficient,
You may also be interested in...
Convergent Calling: An Interview with Medtronic's Stephen Oesterle
Historic walls between the medical device and biotech sectors are coming down as medical devices incorporate more biologically-active agents as part of their therapy. That's good news for device companies since device technology in these combination devices is every bit as critical to their clinical success as the biologic.
TransEnterix Names New CFO, Reports Negative Q2 Earnings Amid Challenging Times
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Need a specific report? 1000+ reports available
Buy Reports